{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:31:26Z","timestamp":1793633486033,"version":"4.5.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["EEC 1648035"],"award-info":[{"award-number":["EEC 1648035"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA278051"],"award-info":[{"award-number":["R01 CA278051"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35 GM119644"],"award-info":[{"award-number":["R35 GM119644"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001395","name":"Wisconsin Alumni Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012787","name":"Office of the Vice Chancellor for Research and Graduate Education, University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.omtn.2026.103081","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:11:41Z","timestamp":1788390701000},"page":"103081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles"],"prefix":"10.1016","volume":"37","author":[{"given":"Apoorva","family":"Ramamurthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Scimonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2837-0858","authenticated-orcid":false,"given":"Krishanu","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103081_bib1","article-title":"CAR-T cell therapy in hematological malignancies: Current opportunities and challenges","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.103081_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41409-024-02429-6","article-title":"CAR-T cell therapy embarks on autoimmune disease","volume":"60","author":"Rampotas","year":"2025","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.omtn.2026.103081_bib3","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(23)01126-1","article-title":"CAR T-cell therapy in autoimmune diseases","volume":"402","author":"Schett","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2026.103081_bib4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.18609\/cgti.2023.132","article-title":"Harnessing chimeric antigen receptor (CAR)-T cells as a potential treatment for Alzheimer\u2019s disease","volume":"9","author":"Sarko","year":"2023","journal-title":"Cell Gene Ther. Insights"},{"key":"10.1016\/j.omtn.2026.103081_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102931","article-title":"CAR-T design: Elements and their synergistic function","volume":"58","author":"Jayaraman","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2026.103081_bib6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13287-020-01741-4","article-title":"Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies","volume":"11","author":"Shankar","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.omtn.2026.103081_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41392-023-01653-8","article-title":"\u03b3\u03b4 T cells: origin and fate, subsets, diseases and immunotherapy","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduction Targeted Ther."},{"key":"10.1016\/j.omtn.2026.103081_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cobme.2020.06.002","article-title":"Engineered multicellular niches for pluripotent stem cell\u2013derived immunotherapy","volume":"16","author":"Smerchansky","year":"2020","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"10.1016\/j.omtn.2026.103081_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188049","article-title":"From bench to bedside: the history and progress of CAR T cell therapy","volume":"14","author":"Mitra","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.103081_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7150\/jca.48976","article-title":"Current progress in CAR-T cell therapy for hematological malignancies","volume":"12","author":"Han","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.omtn.2026.103081_bib11","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/S2352-3026(24)00273-4","article-title":"Accelerating and optimising CAR T-cell manufacture to deliver better patient products","volume":"12","author":"Agliardi","year":"2025","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.omtn.2026.103081_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41388-020-01501-x","article-title":"Counteracting CAR T cell dysfunction","volume":"40","author":"Poorebrahim","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2026.103081_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101840","article-title":"Beyond youth: Understanding CAR T cell fitness in the context of immunological aging","volume":"70","author":"Noll","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.omtn.2026.103081_bib14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41408-023-00958-9","article-title":"The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma","volume":"13","author":"Zhao","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.omtn.2026.103081_bib15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41587-024-02446-2","article-title":"Beyond the blood: expanding CAR T cell therapy to solid tumors","volume":"43","author":"Uslu","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103081_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.193048","article-title":"Enhancing the potency of CAR-T cells against solid tumors through transcription factor engineering","volume":"10","author":"Chen","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtn.2026.103081_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41571-024-00959-y","article-title":"Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks","volume":"22","author":"Diorio","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omtn.2026.103081_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-019-0051-2","article-title":"\u201cOff-the-shelf\u201d allogeneic CAR T cells: development and challenges","volume":"19","author":"Depil","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.103081_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100677","article-title":"Emerging trends in clinical allogeneic CAR cell therapy","volume":"6","author":"Li","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.omtn.2026.103081_bib20","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1038\/s41467-023-44176-0","article-title":"Cyclosporine A-resistant CAR-T cells mediate antitumour immunity in the presence of allogeneic cells","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103081_bib21","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.ymthe.2024.11.035","article-title":"Managing allorejection in off-the-shelf CAR-engineered cell therapies","volume":"33","author":"Li","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103081_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41591-024-03282-2","article-title":"Allogeneic CD5-specific CAR-T therapy for relapsed\/refractory T-ALL: a phase 1 trial","volume":"31","author":"Pan","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.103081_bib23","doi-asserted-by":"crossref","first-page":"E10907","DOI":"10.1073\/pnas.1809671115","article-title":"Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo","volume":"115","author":"DiTommaso","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103081_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101139","article-title":"Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering","volume":"31","author":"Kitte","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.103081_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004446","article-title":"Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression","volume":"10","author":"Mueller","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omtn.2026.103081_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103081_bib27","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1016\/j.cell.2023.08.041","article-title":"Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells","volume":"186","author":"Tsuchida","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103081_bib28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.trecan.2025.08.001","article-title":"CRISPR tools for T cells: targeting the genome, epigenome, and transcriptome","volume":"11","author":"Wachsmann","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.omtn.2026.103081_bib29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ymthe.2022.12.004","article-title":"Detection of chromosomal alteration after infusion of gene-edited allogeneic CAR T cells","volume":"31","author":"Sasu","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103081_bib30","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1038\/s41375-021-01282-6","article-title":"Base-edited CAR T cells for combinational therapy against T cell malignancies","volume":"35","author":"Georgiadis","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.omtn.2026.103081_bib31","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa2300709","article-title":"Base-edited CAR7 T cells for relapsed T-cell acute lymphoblastic leukemia","volume":"389","author":"Chiesa","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103081_bib32","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood.2022019333","article-title":"Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells","volume":"142","author":"Vavassori","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2026.103081_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301515","article-title":"Ionizable lipid nanoparticles with integrated immune checkpoint inhibition for mRNA CAR T cell engineering","volume":"12","author":"Hamilton","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.omtn.2026.103081_bib34","article-title":"Antigen presenting cell mimetic lipid nanoparticles for rapid mRNA CAR T cell cancer immunotherapy","volume":"36","author":"Metzloff","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2026.103081_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103081_bib36","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1038\/s41467-025-60001-2","article-title":"Efficient mRNA delivery to resting T cells to reverse HIV latency","volume":"16","author":"Cevaal","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103081_bib37","article-title":"Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging","volume":"6","author":"Zhang","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omtn.2026.103081_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2319856121","article-title":"IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation","volume":"121","author":"Tilsed","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103081_bib39","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/2326-6066.CIR-18-0466","article-title":"IL15 enhances CAR-T cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype","volume":"7","author":"Alizadeh","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omtn.2026.103081_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41577-020-00426-6","article-title":"How transcription factors drive choice of the T cell fate","volume":"21","author":"Hosokawa","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2026.103081_bib41","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1038\/s41467-020-19486-2","article-title":"In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo","volume":"11","author":"Parayath","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103081_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1158\/2326-6066.CIR-24-0089","article-title":"Transient EZH2 suppression by tazemetostat during in vitro expansion maintains T-cell stemness and improves adoptive T-cell therapy","volume":"13","author":"Hou","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omtn.2026.103081_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba1786","article-title":"Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling","volume":"372","author":"Weber","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103081_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ymthe.2018.12.009","article-title":"MRNA-based genetic reprogramming","volume":"27","author":"Warren","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103081_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-024-07300-8","article-title":"FOXO1 is a master regulator of memory programming in CAR T cells","volume":"629","author":"Doan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103081_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41586-025-08795-5","article-title":"Genome-wide CRISPR screen in human T cells reveals regulators of FOXP3","volume":"642","author":"Chen","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103081_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12943-022-01559-z","article-title":"Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing","volume":"21","author":"Dimitri","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omtn.2026.103081_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/science.aab4077","article-title":"Remote control of therapeutic T cells through a small molecule-gated chimeric receptor","volume":"350","author":"Wu","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103081_bib49","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/eji.200425635","article-title":"Distinct temporal programming of naive CD4+ T cells for cell division versus TCR-dependent death susceptibility by antigen-presenting macrophages","volume":"35","author":"Schrum","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtn.2026.103081_bib50","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.ymthe.2025.04.006","article-title":"High-dimensional temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturing","volume":"33","author":"Cadinanos-Garai","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103081_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102610","article-title":"Lipid nanoparticles produce chimeric antigen receptor macrophages (CAR-M) in situ for the treatment of solid tumors","volume":"61","author":"Zhou","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.omtn.2026.103081_bib52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41467-017-00505-8","article-title":"Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers","volume":"8","author":"Moffett","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103081_bib53","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1096\/fj.14-259531","article-title":"Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human cells","volume":"29","author":"Ramunas","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.omtn.2026.103081_bib54","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nbt.2678","article-title":"Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy","volume":"31","author":"Themeli","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103081_bib55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tibtech.2024.07.012","article-title":"Therapeutic applications of cell engineering using mRNA technology","volume":"43","author":"He","year":"2025","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.omtn.2026.103081_bib56","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s43587-023-00560-5","article-title":"Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction","volume":"4","author":"Amor","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.omtn.2026.103081_bib57","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1016\/j.ymthe.2026.05.029","article-title":"Directing fratricide within T cell products using an anti-uPAR chimeric antigen receptor to drive the production of potent therapeutic cells","volume":"34","author":"Sarko","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103081_bib58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103081_bib59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1208\/s12249-022-02294-w","article-title":"Optimization of DOTAP\/chol cationic lipid nanoparticles for mRNA, pDNA, and oligonucleotide delivery","volume":"23","author":"Sun","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.omtn.2026.103081_bib60","article-title":"Enhancing CAR-NK cells against solid tumors through chemical and genetic fortification with DOTAP-functionalized lipid nanoparticles","volume":"34","author":"Shin","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.omtn.2026.103081_bib61","doi-asserted-by":"crossref","first-page":"29804","DOI":"10.1021\/acsomega.5c04308","article-title":"Precondensed Plasmid DNA enhances CAR-T cell generation via lipid nanoparticles","volume":"10","author":"Pirrottina","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.omtn.2026.103081_bib62","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41434-019-0095-2","article-title":"Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA","volume":"26","author":"Blakney","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2026.103081_bib63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2026.103081_bib64","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.bbamem.2015.06.020","article-title":"DOTAP\/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes","volume":"1848","author":"Kim","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2026.103081_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300123","article-title":"Exploration of mRNA nanoparticles based on DOTAP through optimization of the helper lipids","volume":"18","author":"Ma","year":"2023","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omtn.2026.103081_bib66","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103081_bib67","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.bpj.2023.01.031","article-title":"DOTAP: Structure, hydration, and the counterion effect","volume":"122","author":"Mihailescu","year":"2023","journal-title":"Biophys. J."},{"key":"10.1016\/j.omtn.2026.103081_bib68","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41587-024-02437-3","article-title":"Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 ribonucleoprotein","volume":"43","author":"Chen","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103081_bib69","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1038\/s41467-023-42948-2","article-title":"Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models","volume":"14","author":"Wei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103081_bib70","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2024.08.016","article-title":"The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNA","volume":"374","author":"Barbieri","year":"2024","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.omtn.2026.103081_bib71","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1038\/s41596-024-01134-4","article-title":"mRNA lipid nanoparticle formulation, characterization and evaluation","volume":"20","author":"Ma","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2026.103081_bib72","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41467-019-13997-3","article-title":"Macropinocytosis drives T cell growth by sustaining the activation of mTORC1","volume":"11","author":"Charpentier","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103081_bib73","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/mt.2013.54","article-title":"Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis","volume":"21","author":"El-Sayed","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103081_bib74","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/mp200374e","article-title":"Cholesterol-dependent macropinocytosis and endosomal escape control the transfection efficiency of lipoplexes in CHO living cells","volume":"9","author":"Cardarelli","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtn.2026.103081_bib75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13059-023-02928-7","article-title":"Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells","volume":"24","author":"Glaser","year":"2023","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2026.103081_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45197-x","article-title":"Comparison of two lab-scale protocols for enhanced mRNA-based CAR-T cell generation and functionality","volume":"13","author":"von Auw","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103081_bib77","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1038\/s41467-019-13007-6","article-title":"Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors","volume":"10","author":"Webber","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103081_bib78","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41592-021-01328-8","article-title":"Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4+ T cells allows complex functional analyses","volume":"19","author":"Albanese","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.103081_bib79","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2427216122","article-title":"Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR\/Cas9 nuclease-engineered T cells","volume":"122","author":"Engel","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103081_bib80","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.3389\/fimmu.2018.02503","article-title":"Efficient and non-genotoxic RNA-based engineering of human T cells using tumor-specific T cell receptors with minimal TCR mispairing","volume":"9","author":"Campillo-Davo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.103081_bib81","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1073\/pnas.1712963115","article-title":"Nonviral gene editing via CRISPR\/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103081_bib82","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103081_bib83","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/2211-5463.13292","article-title":"Optimized two-step electroporation process to achieve efficient nonviral-mediated gene insertion into primary T cells","volume":"12","author":"Yang","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.omtn.2026.103081_bib84","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/hum.2023.128","article-title":"Genome editing in engineered T cells for cancer immunotherapy","volume":"34","author":"Bonini","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.103081_bib85","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103081_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2026.102929","article-title":"Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation","volume":"37","author":"Picht","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103081_bib87","first-page":"1","article-title":"Elucidating lipid nanoparticle properties and structure through biophysical analyses","author":"Padilla","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103081_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101299","article-title":"Toward a large-batch manufacturing process for silicon-stabilized lipid nanoparticles: A highly customizable RNA delivery platform","volume":"32","author":"Saffie-Siebert","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.103081_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116285","article-title":"Systematic optimization of siRNA productive uptake into resting and activated T cells ex vivo","volume":"172","author":"Kremer","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtn.2026.103081_bib90","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/acs.nanolett.9b04246","article-title":"Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering","volume":"20","author":"Billingsley","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.omtn.2026.103081_bib91","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejpb.2023.10.006","article-title":"The mixing method used to formulate lipid nanoparticles affects mRNA delivery efficacy and organ tropism","volume":"192","author":"Strelkova Petersen","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.omtn.2026.103081_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304378","article-title":"In vivo mRNA CAR T cell engineering via targeted ionizable lipid nanoparticles with extrahepatic tropism","volume":"20","author":"Billingsley","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.omtn.2026.103081_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202521507","article-title":"Cationic mRNA lipid nanoparticles for ex vivo NanoCAR-T cell engineering","volume":"13","author":"Harinck","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtn.2026.103081_bib94","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Zhang","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2026.103081_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.cocis.2023.101705","article-title":"Review of structural design guiding the development of lipid nanoparticles for nucleic acid delivery","volume":"66","author":"C\u00e1rdenas","year":"2023","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.omtn.2026.103081_bib96","article-title":"Antigen presenting cell mimetic lipid nanoparticles for rapid mRNA CAR T cell cancer immunotherapy (adv. Mater. 26\/2024)","volume":"36","author":"Metzloff","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2026.103081_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.omtn.2026.103081_bib98","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2021.12.027","article-title":"Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)","volume":"344","author":"Parhiz","year":"2022","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.omtn.2026.103081_bib99","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ymthe.2022.04.011","article-title":"Pro-inflammatory concerns with lipid nanoparticles","volume":"30","author":"Moghimi","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103081_bib100","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103081_bib101","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/s41551-024-01256-w","article-title":"Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d","volume":"8","author":"Chaudhary","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtn.2026.103081_bib102","doi-asserted-by":"crossref","first-page":"41836","DOI":"10.1021\/acsnano.5c15903","article-title":"Customizable mRNA lipid nanoparticles for transfection of primary human T cells","volume":"19","author":"VanKeulen-Miller","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtn.2026.103081_bib103","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1021\/acsnano.3c02268","article-title":"Ionizable lipid nanoparticles for therapeutic base editing of congenital brain disease","volume":"17","author":"Palanki","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtn.2026.103081_bib104","article-title":"Hydroxyapatite binding peptide lipid nanoparticles for biomimetic mRNA delivery to bone","volume":"8","author":"Choe","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.omtn.2026.103081_bib105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA","volume":"15","author":"Baiersd\u00f6rfer","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:17:58Z","timestamp":1793632678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126002520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2162253126002520"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103081","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103081"}}